TABLE 1.
Variables | N | Preoperative IBI | p value |
---|---|---|---|
Median (IQR) | |||
Sex | |||
Male | 327 | 0.37 (0.12–1.37) | 0.03 a ,* |
Female | 228 | 0.26 (0.08–1.53) | |
Median age (y) | |||
>68 | 276 | 0.36 (0.11–1.33) | 0.49 a |
≤68 | 279 | 0.29 (0.1–1.53) | |
Neoadjuvant therapy | |||
Yes | 68 | 0.39 (0.12–2.21) | 0.33 a |
No | 487 | 0.33 (0.1–1.39) | |
Obstruction/perforation/abscess | |||
Present | 41 | 6.84 (0.57–22.0) | <0.0001 a ,* |
Absent | 514 | 0.29 (0.09–1.23) | |
Histological type | |||
Differentiated | 502 | 0.3 (0.1–1.23) | <0.0001 a ,* |
Undifferentiated | 53 | 1.33 (0.33–20.1) | |
Location | |||
Colon | 339 | 0.4 (0.1–2.16) | 0.02 a ,* |
Rectum | 216 | 0.27 (0.09–1.04) | |
Pathological T category | |||
pT1/T2 | 189 | 0.15 (0.06–0.39) | <0.0001 a ,* |
pT3/T4 | 366 | 0.56 (0.17–3.72) | |
Venous invasion | |||
Present | 269 | 0.42 (0.12–2.98) | 0.002 a ,* |
Absent | 286 | 0.25 (0.08–1.02) | |
Lymphatic invasion | |||
Present | 367 | 0.44 (0.12–2.75) | <0.0001 a ,* |
Absent | 188 | 0.22 (0.08–0.77) | |
Lymph node metastasis | |||
Present | 225 | 0.58 (0.16–3.77) | <0.0001 a ,* |
Absent | 330 | 0.25 (0.08–0.89) | |
Distant metastasis | |||
Present | 102 | 1.92 (0.44–9.37) | <0.0001 a ,* |
Absent | 453 | 0.25 (0.08–0.9) | |
UICC stage classification | |||
Stage I | 157 | 0.13 (0.06–0.36) | <0.0001 b ,* |
Stage II | 149 | 0.37 (0.14–1.76) | |
Stage III | 147 | 0.34 (0.12–1.08) | |
Stage IV | 102 | 1.92 (0.44–9.37) |
Abbreviations: CRC, colorectal cancer; IBI, Inflammatory Burden Index; IQR, interquartile range.
Mann–Whitney test.
Kruskal–Wallis test.
p < 0.05.